The Centre has directed states and Union Territories to strengthen monitoring of the supply chain and promotion of GLP-1 weight-loss drugs. Regulators have also been asked to act against surrogate advertisements and misleading campaigns that encourage unsupervised use of prescription medicines
Dermatologists warned that rapid weight loss linked to GLP-1 drugs such as Ozempic, Wegovy and Mounjaro may trigger temporary hair shedding, popularly called "Ozempic Hair", urging medically supervised use, balanced nutrition and avoiding unsupervised or over-the-counter consumption
Drugs Control Administration Telangana issued a high-priority advisory on Semaglutide use, warning against self-medication and online purchases. Authorities stressed prescription-only access amid rising demand after patent expiry and cautioned about serious health risks from misuse
The Indian government has intensified surveillance on unauthorised sale and promotion of GLP-1 receptor agonists, conducting nationwide inspections and issuing advisories. Authorities warned of strict action against violations, stressing patient safety amid rising misuse risks without proper medical supervision
